{"id":624,"date":"2021-04-05T09:00:21","date_gmt":"2021-04-05T00:00:21","guid":{"rendered":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/?p=624"},"modified":"2021-04-05T10:12:15","modified_gmt":"2021-04-05T01:12:15","slug":"2020%e5%b9%b4%ef%bc%88%e4%bb%a4%e5%92%8c2%e5%b9%b4%e5%ba%a6%ef%bc%89%e3%81%ae%e7%a0%94%e7%a9%b6%e6%a5%ad%e7%b8%be","status":"publish","type":"post","link":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/achievement\/20210405624\/","title":{"rendered":"2020\u5e74\uff08\u4ee4\u548c2\u5e74\u5ea6\uff09\u306e\u7814\u7a76\u696d\u7e3e"},"content":{"rendered":"

A. \u8ad6\u6587<\/h3>\n<\/ol>\n

\u3010\u539f\u8457\u3011<\/h4>\n
    \n
  1. Umekita K, Hashiba Y, Iwao K, Iwao C, Kimura M, Kariya Y, Kubo K, Miyauchi S, Kudou R, Rikitake Y, Takajo K, Kawaguchi T, Matsuda M, Takajo I, Inoue E, Hidaka T, Okayama A. Human T-cell leukemia virus type 1 may invalidate T-SPOT.TB assay results in rheumatoid arthritis patients: A retrospective case-control observational study. PLoS One. 2020 May 27;15(5):e0233159. doi: 10.1371\/journal.pone.0233159. eCollection 2020.<\/li>\n
  2. Umeki K, Yasuda A, Umekita K, Megumi R, Nomura H, Kawaguchi T, Matsuda M, Takajo I, Shimojima M, Okayama A. Detection of anti-SFTSV nuclear protein antibody in the acute phase sera of patients using double-antigen ELISA and immunochromatography. J Virol Methods. 2020 Aug 8;113942. doi: 10.1016\/j.jviromet.2020.113942. Online ahead of print.<\/li>\n
  3. Okuma K, Kuramitsu M, Niwa T, Taniguchi T, Masaki Y, Ueda G, Matsumoto C, Sobata R, Sagara Y, Nakamura H, Satake M, Miura K, Fuchi N, Masuzaki H, Okayama A, Umeki K, Yamano Y, Sato T, Iwanaga M, Uchimaru K, Nakashima M, Utsunomiya A, Kubota R, Ishitsuka K, Hasegawa H, Sasaki D, Koh K, Taki M, Nosaka K, Ogata M, Naruse I, Kaneko N, Okajima S, Tezuka K, Ikebe E, Matsuoka S, Itabashi K, Saito S, Watanabe T, Hamaguchi I. Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan. Retrovirology. 2020 ;17(1):26. (Aug 24) doi: 10.1186\/s12977-020-00534-0.<\/li>\n
  4. Kawaguchi T, Umekita K, Yamanaka A, Hara S, Yamaguchi T, Inoue E, Okayama A. Impact of C-reactive protein levels on differentiating of severe fever with thrombocytopenia syndrome from Japanese spotted fever. Open Forum Infectious Diseases. ofaa473, https:\/\/doi.org\/10.1093\/ofid\/ofaa473 Published: 07 October 2020 Article history<\/li>\n
  5. Endo Y, Fukui S, Umekita K, Suzuki T, Miyamoto J, Morimoto S, Shimizu T, Koga T, Kawashiri S, Iwamoto N, Ichinose K, Tamai M, Origuchi T, Okada A, Fujikawa K, Mizokami A, Matsuoka N, Aramaki T, Ueki Y, Eguchi K, Kariya Y, Hashiba Y, Hidaka T, Okayama A, Kawakami A, Nakamura H. Effectiveness and safety of non-tumor necrosis factor inhibitor therapy for anti-human T-cell leukemia virus type 1 antibody-positive rheumatoid arthritis. Mod Rheumatol. 2020 Nov 9;1-17. doi: 10.1080\/14397595.2020.1847802. Online ahead of print.<\/li>\n
  6. \u5916\u5c71\u667a\u7ae0, \u5e73\u539f\u5eb7\u5bff, \u5ca9\u5c3e\u5343\u7d18, \u4e2d\u5c71\u96c4\u8cb4, \u8352\u6b66\u821e, \u5c71\u7530\u660e\u8f1d, \u5ca1\u5c71\u662d\u5f66, \u6c60\u7530\u9f8d\u4e8c. \u6297\u83cc\u85ac\u9069\u6b63\u4f7f\u7528\u63a8\u9032\u306b\u5411\u3051\u305f\u5f53\u9662\u306e\u73fe\u72b6\u628a\u63e1\u53ca\u3073\u53d6\u308a\u7d44\u307f. \u4e5d\u5dde\u85ac\u5b66\u4f1a\u96d1\u8a8c. 2020; 74: 23-26. (11\u6708)<\/li>\n
  7. Ohsawa I, Fukunaga A. Imamura S, Iwamoto K, Tanaka A, Hide M, Honda D, Yamashita K, Fujiwara C, Ishikawa O, Yamaguchi T, Maehara J, Hirose T, Ieko M, Umekita K, Nakamura Y, Gotoh H. Survey of actual conditions of erythema marginatum as a prodromal symptom in Japanese patients with hereditary angioedema. World Allergy Organization Journal. 2021; 14:100511 http:\/\/ doi.org\/10.1016\/j.waojou.2021.100511 Online publication<\/li>\n
  8. \u5bae\u5185\u4fca\u4e00, \u5de5\u85e4\u7406\u7d17, \u6728\u6751\u8ce2\u4fca, \u5ca9\u5c3e\u5343\u7d18, \u529b\u6b66\u96c4\u5e79, \u5ca9\u5c3e\u6d69\u662d, \u529b\u6b66\u771f\u592e, \u76f8\u6fa4\u5f69\u5b50, \u5ddd\u53e3\u525b, \u4eee\u5c4b\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. HTLV-1\u967d\u6027\u5168\u8eab\u6027\u5f37\u76ae\u75c7\u306e\u81e8\u5e8a\u7684\u7279\u5fb4. \u4e5d\u5dde\u30ea\u30a6\u30de\u30c1. 2021; 41(1): 37-42.<\/li>\n<\/ol>\n

    \u3010\u75c7\u4f8b\u5831\u544a\uff08\u8ad6\u6587\uff09\u3011<\/h4>\n
      \n
    1. Iwao C, Umekita K, Miyauchi S, Kimura M, Rikitake Y, Iwao K, Rikitake M, Aizawa A, Kawaguchi T, Kariya Y, Matsuda M, Takajo I, Shiomi K, Okayama A. Effective Treatment with Tocilizumab in a Rheumatoid Arthritis Patient Complicated with Human T-cell Leukemia Virus Type 1-associated Myelopathy: A Case Report. Intern Med. 2020; 59(15):1891-1897. (Aug) doi: 10.2169\/internalmedicine.4455-20.<\/li>\n
    2. Hashiba Y, Umekita K, Minami H, Kawano A, Nagayasu E, Haruhiko Maruyama H, Hidaka T, Okayama A. Strongyloides stercoralis colitis in a patient positive for human T-cell leukemia virus with rheumatoid arthritis during an anti-rheumatic therapy: a case report. Mod Rheumatol Case Rep. 2021 ;5(1):16-21. (Jan) 2020 Aug 24;1-6. doi: 10.1080\/24725625.2020.1808304. Online ahead of print.<\/li>\n
    3. Nakashima S, Takajo I, Maruyama H, Nagayasu E. Abdominal paragonimiasis after consumption of wild boar meat. Int J Infect Dis. 2021; 105:40-41 (Feb)<\/li>\n
    4. Kawaguchi T, Himeji D, Beppu K, Marutsuka K. Snowball\u2010like appearance on radial endobronchial ultrasonography in a patient with invasive mucinous adenocarcinoma. Respirology Case Report. 2021; 9(4) e00735. (March)<\/li>\n<\/ol>\n

      \u3010\u7dcf\u8aac\u3011<\/h4>\n
        \n
      1. \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. \u7279\u96c6 HTLV-1\u6bcd\u5b50\u611f\u67d3\u3092\u3082\u3063\u3068\u77e5\u308d\u3046\u3000HTLV-\u95a2\u9023\u75be\u60a3 ATL,HAM\u4ee5\u5916\u306e\u95a2\u9023\u75be\u60a3. \u5468\u7523\u671f\u533b\u5b66. 2020; 50(10):1703-1706.(10\u670810\u65e5)<\/li>\n
      2. \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. \u514d\u75ab\u30fb\u708e\u75c7\u75be\u60a3\u306e\u3059\u3079\u3066 VI\u514d\u75ab\u30fb\u708e\u75c7\u75be\u60a3\u5404\u8ad6\uff0f\u75c5\u539f\u5fae\u751f\u7269\u30fb\u65b0\u751f\u7269\u306b\u60f9\u8d77\u3055\u308c\u308b\u514d\u75ab\u75be\u60a3\u30d2\u30c8T\u7d30\u80de\u767d\u8840\u75c5\u30a6\u30a4\u30eb\u30b91\u578b(HTLV-1). \u65e5\u672c\u533b\u5e2b\u4f1a\u96d1\u8a8c. 2020; 149\u7279\u5225\u53f7(2):318-320.(10\u670815\u65e5)<\/li>\n
      3. \u5ca1\u5c71\u662d\u5f66, \u9ad8\u57ce\u4e00\u90ce. \u65b0\u578b\u30b3\u30ed\u30ca\u6642\u4ee3\u306e\u6297\u83cc\u85ac\u9069\u6b63\u4f7f\u7528. \u5bae\u5d0e\u770c\u5185\u79d1\u533b\u4f1a\u8a8c. 2020; 96: 4-8. (10\u670831\u65e5)<\/li>\n<\/ol>\n
        \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/a><\/div>\n

        B. \u767a\u8868<\/h3>\n

        \u3010\u5b66\u4f1a\u767a\u8868\u3011<\/h4>\n
          \n
        1. \u5185\u7530\u572d\u7950, \u529b\u6b66\u96c4\u5e79, \u5bae\u5185\u4fca\u4e00, \u5c0f\u5c71\u5f70\u5e73, \u5c0f\u7530\u5eb7\u6674, \u9234\u6728\u7fd4, \u5ca1\u5c71\u662d\u5f66, \u5c0f\u677e\u5f18\u5e78. ST\u5408\u5264\u306e\u6e1b\u611f\u4f5c\u7642\u6cd5\u3092\u884c\u3063\u305fHIV\u95a2\u9023\u30cb\u30e5\u30fc\u30e2\u30b7\u30b9\u30c1\u30b9\u80ba\u708e. \u7b2c117\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u8b1b\u6f14\u4f1a \u533b\u5b66\u751f\u30fb\u7814\u4fee\u533b\u306e\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u3053\u3068\u306f\u3058\u3081 2020\u6771\u4eac. \u53e3\u6f14 ZOOM, 2020. (8\u67088\u65e5,\u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
        2. \u5ddd\u53e3\u525b, \u5de5\u85e4\u7406\u7d17, \u6728\u6751\u8ce2\u4fca, \u529b\u6b66\u96c4\u5e79, \u5ca9\u5c3e\u5343\u7d18, \u5ca9\u5c3e\u6d69\u662d, \u4eee\u5c4b\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u5168\u8eab\u6027\u5f37\u76ae\u75c7\u95a2\u9023\u9593\u8cea\u6027\u80ba\u708e(SSc-ILD)\u306b\u304a\u3051\u308b\u4e88\u5f8c\u4e0d\u826f\u56e0\u5b50\u306e\u691c\u8a0e: \u5f8c\u65b9\u8996\u7684\u691c\u8a0e. \u7b2c64\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u30dd\u30b9\u30bf\u30fc. 2020. (8\u670817\u65e5-9\u670815\u65e5,web\u958b\u50ac) \u79c0\u9038\u30dd\u30b9\u30bf\u30fc\u53d7\u8cde<\/li>\n
        3. \u6728\u6751\u8ce2\u4fca, \u6885\u5317\u90a6\u5f66, \u5de5\u85e4\u7406\u7d17, \u5ca9\u5c3e\u5343\u7d18, \u529b\u6b66\u96c4\u5e79, \u529b\u6b66\u771f\u592e, \u5ca9\u5c3e\u6d69\u662d,\u76f8\u6fa4\u5f69\u5b50, \u5ddd\u53e3\u525b, \u4eee\u5c4b\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u6297SRP\u6297\u4f53\u967d\u6027\u58ca\u6b7b\u6027\u30df\u30aa\u30d1\u30c1\u30fc\u304a\u3088\u3073\u6297ARS\u6297\u4f53\u967d\u6027\u76ae\u819a\u7b4b\u708e\u306e\u5927\u817f\u90e8MRI\u6240\u898b\u306e\u6bd4\u8f03\u691c\u8a0e. \u7b2c64\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u53e3\u6f14. 2020. (8\u670817\u65e5-9\u670815\u65e5,web\u958b\u50ac)<\/li>\n
        4. \u5ca1\u5c71\u662d\u5f66. \u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7. \u4ee4\u548c2\u5e74\u5ea6\u5bae\u5d0e\u770c\u7523\u5a66\u4eba\u79d1\u533b\u4f1a\u30fb\u5bae\u5d0e\u770c\u7523\u5a66\u4eba\u79d1\u5b66\u4f1a\u3000\u79cb\u671f\u5b9a\u6642\u7dcf\u4f1a\u30fb\u5b66\u8853\u8b1b\u6f14\u4f1a. \u7279\u5225\u8b1b\u6f14. 2020. (9\u670819\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u9928)<\/li>\n
        5. \u5ca1\u5c71\u662d\u5f66. \u65b0\u578b\u30b3\u30ed\u30ca\u6642\u4ee3\u306b\u304a\u3051\u308b\u30b9\u30dd\u30fc\u30c4\u95a2\u9023\u306e\u611f\u67d3\u5bfe\u7b56. \u7b2c31\u56de\u65e5\u672c\u81e8\u5e8a\u30b9\u30dd\u30fc\u30c4\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u6559\u80b2\u7814\u4fee\u8b1b\u6f14. 2020. (11\u67084\u65e5-11\u670830\u65e5,\u30aa\u30f3\u30e9\u30a4\u30f3\u958b\u50ac)<\/li>\n
        6. \u6885\u5317\u90a6\u5f66, \u5ca9\u5c3e\u5343\u7d18, \u5ca9\u5c3e\u6d69\u662d, \u4eee\u5c4b\u88d5\u7f8e, \u5bae\u5185\u4fca\u4e00, \u677e\u7530\u57fa\u5f18, \u6728\u6751\u8ce2\u4fca, \u5ddd\u53e3\u525b, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u30d2\u30c8T\u7d30\u80de\u767d\u8840\u75c5\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u306fT-SPOT.TB\u5224\u5b9a\u4e0d\u80fd\u306e\u8981\u56e0\u3068\u3057\u3066\u91cd\u8981\u3067\u3042\u308b. \u7b2c90\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c63\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c68\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a. \u30dd\u30b9\u30bf\u30fc. 2020. (11\u67085-7\u65e5\uff08\u95b2\u89a7\uff09, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u30a2\u30af\u30ed\u30b9\u798f\u5ca1) \u73fe\u5730\u958b\u50ac\u30fbWEB\u4e2d\u7d99(\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9\u958b\u50ac)<\/li>\n
        7. \u5de5\u85e4\u7406\u7d17, \u5ddd\u53e3\u525b, \u6728\u6751\u8ce2\u4fca, \u529b\u6b66\u96c4\u5e79, \u5ca9\u5c3e\u5343\u7d18, \u5ca9\u5c3e\u6d69\u662d, \u4eee\u5c4b\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u9ad8\u57ce\u4e00\u90ce, \u77e2\u53e3\u8cb4\u5fd7, \u5ca1\u5c71\u662d\u5f66. \u6210\u4eba\u30b9\u30c6\u30a3\u30eb\u75c5\u306e\u6cbb\u7642\u4e2d\u306b\u767a\u75c7\u3057\u305fNocardia arthritidis\u306b\u3088\u308b\u80ba\u708e. \u30dd\u30b9\u30bf\u30fc. 2020. (11\u67085-7\u65e5\uff08\u95b2\u89a7\uff09, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u30a2\u30af\u30ed\u30b9\u798f\u5ca1) \u73fe\u5730\u958b\u50ac\u30fbWEB\u4e2d\u7d99(\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9\u958b\u50ac)<\/li>\n
        8. \u6885\u5317\u90a6\u5f66. Human T-cell Leukemia Virus Type 1 May Invalidate T-SPOT.TB Assay Results in Rheumatoid Arthritis Patients: A Retrospective Case-Control Observational Study\uff0e\u7b2c90\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c63\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c68\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a. \u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u3000\u611f\u67d3\u75c7\u512a\u79c0\u8ad6\u6587\u8cde \u8b1b\u6f14. 2020. (11\u67085-7\u65e5\uff086\u65e5\u767a\u8868\uff09, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u30a2\u30af\u30ed\u30b9\u798f\u5ca1) <\/li>\n
        9. \u529b\u6b66\u96c4\u5e79, \u5ddd\u53e3\u525b, \u5de5\u85e4\u7406\u7d17, \u6728\u6751\u8ce2\u4fca, \u5ca9\u5c3e\u5343\u7d18, \u5ca9\u5c3e\u6d69\u662d, \u529b\u6b66\u771f\u592e, \u4eee\u5c4b\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u80ba\u75c5\u5909\u3001\u95a2\u7bc0\u708e\u3092\u5448\u3057\u305f\u64ad\u7a2e\u6027\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u611f\u67d3\u75c7\u306e1\u4f8b. \u7b2c90\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c63\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c68\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a. \u53e3\u6f14.\u3000 2020. (11\u67085-7\u65e5\uff087\u65e5ZOOM\u767a\u8868\uff09, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u30a2\u30af\u30ed\u30b9\u798f\u5ca1) \u73fe\u5730\u958b\u50ac\u30fbWEB\u4e2d\u7d99(\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9\u958b\u50ac)<\/li>\n
        10. \u5ca1\u5c71\u662d\u5f66. \u5bae\u5d0e\u770c\u3067\u307f\u3089\u308c\u308b\u611f\u67d3\u75c7\u3068\u30b9\u30dd\u30fc\u30c4\u6642\u306e\u5bfe\u7b56. \u7b2c63\u56de\u5bae\u5d0e\u770c\u30b9\u30dd\u30fc\u30c4\u5b66\u4f1a. \u7279\u5225\u8b1b\u6f14. 2020. (11\u67087\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02,\u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u9928)<\/li>\n
        11. \u6728\u6751\u8ce2\u4fca, \u5ddd\u53e3\u525b, \u5de5\u85e4\u7406\u7d17, \u529b\u6b66\u96c4\u5e79, \u5ca9\u5c3e\u6d69\u662d, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. SLE\u3092\u57fa\u790e\u75be\u60a3\u3068\u3057\u7e70\u308a\u8fd4\u3059\u80ba\u708e\u306e\u5f8c\u306b\u8a3a\u65ad\u3055\u308c\u305f\u80ba\u653e\u7dda\u83cc\u75c7. \u7b2c331\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a. \u53e3\u6f14. 2020. (11\u670829\u65e5, Web\u958b\u50ac)<\/li>\n
        12. \u5ca9\u5c3e\u6d69\u662d, \u677e\u7530\u57fa\u5f18, \u529b\u6b66\u96c4\u5e79,\u3000\u5ddd\u53e3\u525b, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u30b9\u30c6\u30ed\u30a4\u30c9\u958b\u59cb\u5f8c\u306b\u96e3\u6cbb\u6027\u5fc3\u5ba4\u983b\u62cd\u304c\u51fa\u73fe\u3057\u305f\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u306e1\u4f8b. \u7b2c332\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a. \u53e3\u6f14. 2021. (1\u67089\u65e5, Web\u958b\u50ac)<\/li>\n
        13. \u5c71\u7530\u82bd\u751f, \u5c3e\u65b9\u7f8e\u5e78, \u6851\u539f\u5f69, \u7530\u4e2d\u7f8e\u4e0e, \u9234\u6728\u5343\u4ee3\u5b50, \u4e95\u624b\u53e3\u6b66\u53f2, \u53e4\u5ddd\u8ca2\u4e4b, \u77f3\u5ddd\u54f2\u61b2, \u4e2d\u6751\u90fd\u82f1, \u5ca1\u5c71\u662d\u5f66. \u5fc3\u30a8\u30b3\u30fc\u56f3\u691c\u67fb\u304c\u8a3a\u65ad\u306e\u4e00\u52a9\u3068\u306a\u3063\u305f\u5de8\u5927\u51a0\u52d5\u9759\u8108\u763b\u306e2\u4f8b. \u7b2c66\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a \u7b2c32\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u7dcf\u4f1a \u7b2c1\u56de\u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a. \u53e3\u6f14. 2021. (3\u67086\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u3000WEB\u958b\u50ac)<\/li>\n
        14. \u6a4b\u5834\u5f25\u751f, \u6728\u6751\u8ce2\u4fca, \u4e45\u4fdd\u548c\u7fa9, \u9ed2\u7530\u5b8f, \u65e5\u9ad8\u5229\u5f66. \u5f53\u9662\u306e\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u5bfe\u3059\u308b\u30b5\u30ea\u30eb\u30de\u30d6\u306e1\u5e74\u6642\u8a55\u4fa1. \u7b2c61\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u53e3\u6f14. 2021. (3\u670820\u65e5-21\u65e5(20\u65e5\u767a\u8868), LIVE\u914d\u4fe1)<\/li>\n
        15. \u65e5\u9ad8\u5229\u5f66, \u6a4b\u5834\u5f25\u751f, \u6728\u6751\u8ce2\u4fca, \u4e45\u4fdd\u548c\u7fa9. \u751f\u7269\u5b66\u7684\u88fd\u5264\u30fbJAK\u963b\u5bb3\u85ac\u3067\u6cbb\u7642\u4e2d\u306e\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f\u6ce8\u5c04\u85ac\u3068\u7d4c\u53e3\u85ac\u306e\u597d\u307f\u8abf\u67fb. \u7b2c61\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u53e3\u6f14. 2021. (3\u670820\u65e5-21\u65e5(20\u65e5\u767a\u8868), LIVE\u914d\u4fe1)<\/li>\n
        16. \u5de5\u85e4\u7406\u7d17, \u6885\u5317\u90a6\u5f66, \u6728\u6751\u8ce2\u4fca, \u529b\u6b66\u96c4\u5e79, \u5ca9\u5c3e\u6d69\u662d, \u529b\u6b66\u771f\u592e, \u76f8\u6fa4\u5f69\u5b50, \u4eee\u5c4b\u88d5\u7f8e, \u5ddd\u53e3\u525b, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u5f53\u79d1\u306b\u304a\u3051\u308b\u514d\u75ab\u6291\u5236\u7642\u6cd5\u4e2d\u306b\u767a\u751f\u3057\u305f\u30ce\u30ab\u30eb\u30b8\u30a2\u611f\u67d3\u75c75\u4f8b\u306e\u81e8\u5e8a\u7684\u691c\u8a0e. \u7b2c61\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u53e3\u6f14. 2021. (3\u670820\u65e5-21\u65e5(21\u65e5\u767a\u8868), LIVE\u914d\u4fe1)<\/li>\n
        17. \u6728\u6751\u8ce2\u4fca, \u4e45\u4fdd\u548c\u7fa9, \u6a4b\u5834\u5f25\u751f, \u9ed2\u7530\u5b8f, \u65e5\u9ad8\u5229\u5f66. \u751f\u7269\u5b66\u7684\u88fd\u5264\u306b\u6cbb\u7642\u62b5\u6297\u6027\u3092\u793a\u3059\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u5bfe\u3059\u308b\u5f53\u9662\u3067\u306eIguratimod\u306e\u6cbb\u7642\u52b9\u679c. \u7b2c61\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u53e3\u6f14. 2021. (3\u670820\u65e5-21\u65e5(21\u65e5\u767a\u8868), LIVE\u914d\u4fe1)<\/li>\n<\/ol>\n

          \u3010\u7814\u7a76\u4f1a\u767a\u8868\u3011<\/h4>\n
            \n
          1. \u5ddd\u53e3\u525b. \u5b9f\u81e8\u5e8a\u306b\u304a\u3051\u308bPF-ILD\u8a3a\u65ad\u306e\u8ab2\u984c, PF-ILD\u6cbb\u7642\u306b\u304a\u3051\u308b\u8ab2\u984c. PF-ILD Scientific Exchange Meeting in \u4e5d\u5dde. \u30d1\u30cd\u30ea\u30b9\u30c8. 2020. (9\u670812\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u89b3\u5149\u30db\u30c6\u30eb) Online.<\/li>\n
          2. \u6885\u5317\u90a6\u5f66. HTLV-1\u967d\u6027\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u3068IL-6. \u5bae\u5d0eIL-6Expert Forum. \u53e3\u6f14. 2020. (12\u670816\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u89b3\u5149\u30db\u30c6\u30eb)<\/li>\n
          3. \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u5de5\u85e4\u7406\u7d17, \u6728\u6751\u8ce2\u4fca, \u5ca9\u5c3e\u5343\u7d18, \u529b\u6b66\u96c4\u5e79, \u5ca9\u5c3e\u6d69\u662d, \u529b\u6b66\u771f\u592e, \u76f8\u6fa4\u5f69\u5b50, \u5ddd\u53e3\u525b, \u4eee\u5c4b\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. HTLV-1\u967d\u6027\u5168\u8eab\u6027\u5f37\u76ae\u75c7\u306e\u81e8\u5e8a\u7684\u7279\u5fb4. \u7b2c4\u56de\u4e5d\u5dde\u81a0\u539f\u75c5\u96e3\u6cbb\u6027\u75c5\u614b\u6cbb\u7642\u7814\u7a76\u4f1a. \u53e3\u6f14. 2021. (1\u670830\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, ACU-H\u3000\u30ea\u30e2\u30fc\u30c8\u914d\u4fe1)<\/li>\n
          4. \u5ca1\u5c71\u662d\u5f66. \u65b0\u578b\u30b3\u30ed\u30ca\u6642\u4ee3\u306e\u30b9\u30dd\u30fc\u30c4\u611f\u67d3\u5bfe\u7b56. \u7b2c28\u56de\u79cb\u7530\u770c\u30b9\u30dd\u30fc\u30c4\u533b\u5b66\u7814\u7a76\u4f1a. \u53e3\u6f14. 2021. (2\u670820\u65e5, Web\u958b\u50ac)<\/li>\n
          5. 5)\t\u5ca1\u5c71\u662d\u5f66. HTLV-1\u611f\u67d3\u75c7\uff1a\u6bcd\u5b50\u611f\u67d3\u5bfe\u7b56\u3092\u4e2d\u5fc3\u306b. \u4ee4\u548c2\u5e74\u5ea6HTLV-1\u6bcd\u5b50\u611f\u67d3\u5bfe\u7b56\u4e8b\u696d\u7814\u4fee\u4f1a. 2021. (3\u670815\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u9928)Web\u914d\u4fe1<\/li>\n<\/ol>\n

            \u3010\u8b1b\u6f14\u30fb\u30bb\u30df\u30ca\u30fc\u3011<\/h4>\n
              \n
            1. \u9ad8\u57ce\u4e00\u90ce. \u6a19\u6e96\u4e88\u9632\u7b56\u3068\u8077\u696d\u611f\u67d3\u9632\u6b62\u3000\uff5e\u60a3\u8005\u3068\u81ea\u5206\u3092\u5b88\u308b\u305f\u3081\u306b\u306f\uff5e. 2020\u5e74\u5ea6\u65b0\u898f\u63a1\u7528\u8005\u30aa\u30ea\u30a8\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3. 2020. (4\u67082\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
            2. \u9ad8\u57ce\u4e00\u90ce. \u9662\u5185\u611f\u67d3\u5bfe\u7b56. \u4ee4\u548c2\u5e74\u5ea6\u533b\u5b66\u79d11\u5e74\u751f \u65e9\u671f\u5927\u5b66\u75c5\u9662\u5b9f\u7fd2. 2020. (5\u670822\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8)<\/li>\n
            3. \u5ca1\u5c71\u662d\u5f66. \u65b0\u578b\u30b3\u30ed\u30ca\u6642\u4ee3\u306e\u611f\u67d3\u5bfe\u7b56. \u5bae\u5d0e\u6771\u75c5\u9662\u958b\u68df\u8a18\u5ff5\u8b1b\u6f14. 2020. (6\u670826\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u6771\u75c5\u9662)<\/li>\n
            4. \u9ad8\u57ce\u4e00\u90ce. \u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u3092\u542b\u3081\u305f\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u3067\u306e\u611f\u67d3\u75c7\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306b\u3064\u3044\u3066. \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u6cbb\u7642\u85ac\u9069\u6b63\u4f7f\u7528\u8b1b\u6f14\u4f1a(WEB\u914d\u4fe1) 2020. (8\u670831\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u30db\u30c6\u30eb\u30b9\u30ab\u30a4\u30bf\u30ef\u30fc\u5bae\u5d0e\u99c5\u524d)<\/li>\n
            5. \u9ad8\u57ce\u4e00\u90ce. \u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306b\u3064\u3044\u3066. \u4ee4\u548c2\u5e74\u5ea6\u533b\u7642\u5b89\u5168\u7ba1\u7406\u30fb\u611f\u67d3\u5bfe\u7b56\u8b1b\u6f14\u4f1a. 2020. (9\u67088\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
            6. \u5ca1\u5c71\u662d\u5f66. HTLV-1\u611f\u67d3\u3068\u708e\u75c7\u6027\u75be\u60a3. \u30b7\u30b9\u30e1\u30c3\u30af\u30b9\u30a4\u30e0\u30ce\u30ed\u30b8\u30fc WEB\u30bb\u30df\u30ca\u30fcin \u9577\u5d0e. 2020. (10\u670816\u65e5, WEB\u30bb\u30df\u30ca\u30fc)<\/li>\n
            7. \u9ad8\u57ce\u4e00\u90ce. \u30b3\u30ed\u30ca\u798d\u306b\u304a\u3051\u308b\u611f\u67d3\u75c7\u8a3a\u7642\u306b\u3064\u3044\u3066 \uff5e\u5bae\u5d0e\u770c\u5185\u306e\u72b6\u6cc1\u3092\u8e0f\u307e\u3048\u3066\uff5e. \u611f\u67d3\u75c7WEB\u30bb\u30df\u30ca\u30fcin \u5bae\u5d0e. 2020. (11\u670818\u65e5, WEB\u8b1b\u6f14\u4f1a)\n
            8. \u5ca1\u5c71\u662d\u5f66. \u5f53\u9662\u306b\u304a\u3051\u308b\u611f\u67d3\u5bfe\u7b562020. \u4ee4\u548c2\u5e74\u5ea6\u533b\u7642\u5b89\u5168\u7ba1\u7406\u30fb\u611f\u67d3\u5bfe\u7b56\u8b1b\u6f14\u4f1a. 2020. (11\u670827\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
            9. \u9ad8\u57ce\u4e00\u90ce. \u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306b\u3064\u3044\u3066. \u4ee4\u548c2\u5e74\u5ea6\u5bae\u5d0e\u770c\u8a8d\u77e5\u75c7\u9ad8\u9f62\u8005\u30b0\u30eb\u30fc\u30d7\u30db\u30fc\u30e0\u9023\u7d61\u5354\u8b70\u4f1a\u5168\u4f53\u7814\u4fee\u4f1a. 2020. (12\u67089\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, Web\u304a\u3088\u3073\u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u9928)<\/li>\n
            10. \u9ad8\u57ce\u4e00\u90ce. \u9ad8\u9f62\u8005\u65bd\u8a2d\u306b\u304a\u3051\u308b\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u5bfe\u7b56. \u9ad8\u9f62\u8005\u65bd\u8a2d\u306b\u304a\u3051\u308b\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u5bfe\u7b56\u8b1b\u6f14\u4f1a. 2020. (12\u670817\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u7530\u91ce\u6587\u5316\u4f1a\u9928,ZOOM\u914d\u4fe1\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9\u958b\u50ac)<\/li>\n
            11. \u6a4b\u5834\u5f25\u751f. \u98a8\u306b\u7acb\u3064\u30e9\u30a4\u30aa\u30f3\u306b\u61a7\u308c\u3066\uff5e\u5b50\u30e9\u30a4\u30aa\u30f3\u305f\u3061\u306e\u305d\u306e\u5f8c\uff5e. \u547d\u3092\u8003\u3048\u308b\u8b1b\u6f14\u4f1a. \u5ea7\u8ac7\u4f1a. 2020. (12\u670818\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u81e8\u5e8a\u8b1b\u7fa9\u5ba4\u3001ZOOM\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9\u958b\u50ac)<\/li>\n
            12. \u5ca1\u5c71\u662d\u5f66. \u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u3068\u30b9\u30dd\u30fc\u30c4. \u4ee4\u548c2\u5e74\u5ea6\u30b9\u30dd\u30fc\u30c4\u30c9\u30af\u30bf\u30fc\u9023\u76df\u7dcf\u4f1a \u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u30b9\u30dd\u30fc\u30c4\u533b\u5b66\u30bb\u30df\u30ca\u30fc. 2021. (2\u67081\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u9928, Web\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9)<\/li>\n
            13. \u5ca1\u5c71\u662d\u5f66. \u75c5\u9662\u74b0\u5883\u3082\u8003\u3048\u305f\u9662\u5185\u611f\u67d3\u5bfe\u7b56. \u96e3\u6cbb\u6027\u611f\u67d3\u75c7Virtual Meeting. 2021. (2\u67089\u65e5, Web\u914d\u4fe1\u958b\u50ac)<\/li>\n
            14. \u5ca1\u5c71\u662d\u5f66. \u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306b\u3064\u3044\u3066. \u4ee4\u548c2\u5e74\u5ea6\u65e5\u5411\u5e02\u6771\u81fc\u6775\u90e1\u533b\u5e2b\u4f1a\u5728\u5b85\u533b\u7642\u591a\u8077\u7a2e\u7814\u4fee\u4f1a. 2021. (2\u670815\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u9928\u3000Web\u767a\u4fe1)<\/li>\n
            15. \u9ad8\u57ce\u4e00\u90ce. \u30c7\u30a4\u30fb\u30b1\u30a2\u306b\u304a\u3051\u308b\u611f\u67d3\u75c7\u5bfe\u7b56. \u7b2c23\u56de\u5bae\u5d0e\u770c\u8001\u4eba\u30c7\u30a4\u30b1\u30a2\u7814\u7a76\u5927\u4f1a. 2021. (2\u670821\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u30e1\u30c7\u30a3\u30ad\u30c3\u30c8\u770c\u6c11\u6587\u5316\u30bb\u30f3\u30bf\u30fc\u3000Web\u767a\u4fe1)<\/li>\n
            16. \u5ca1\u5c71\u662d\u5f66. \u5730\u57df\u533b\u7642\u3068\u611f\u67d3\u75c7\u5bfe\u7b56. \u90fd\u57ce\u5e02\u5317\u8af8\u770c\u90e1\u533b\u5e2b\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. 2021. (3\u67081\u65e5, \u5bae\u5d0e\u770c\u90fd\u57ce\u5e02, \u90fd\u57ce\u5e02\u5317\u8af8\u770c\u90e1\u533b\u5e2b\u4f1a\u9928)<\/li>\n<\/ol>\n

              \u3010\u305d\u306e\u4ed6\u3011<\/h4>\n
                \n
              1. \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. \u30ec\u30b8\u30b9\u30c8\u30ea\u69cb\u7bc9\u3068RA\u60a3\u8005\u8a3a\u7642\u306b\u304a\u3051\u308bHTLV-1\u30ea\u30b9\u30af. \u4ee4\u548c2\u5e74\u5ea6\u7b2c1\u56de\u30a8\u30d3\u30c7\u30f3\u30b9\u5c71\u91ce\u73ed\u4f1a\u8b70. 2020. (8\u670810\u65e5, Web\u4f1a\u8b70 \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u30eb\u30fc\u30e0)<\/li>\n
              2. \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. \u300cHTLV-1\u967d\u6027\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u8a3a\u7642\u306e\u624b\u5f15\u300d\u30a2\u30f3\u30b1\u30fc\u30c8\u8abf\u67fb\u7d50\u679c\u5831\u544a. \u4ee4\u548c2\u5e74\u5ea6AMED\u30fb\u539a\u52b4\u79d1\u7814\u8cbbHAM\u95a2\u9023\u7814\u7a76\u73ed\u5408\u540c\u73ed\u4f1a\u8b70. 2020. (12\u670813\u65e5,Zoom\u306b\u3088\u308bWeb\u958b\u50ac\u65b9\u5f0f)<\/li>\n
              3. \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. HTLV-1\u967d\u6027\u30ea\u30a6\u30de\u30c1\u6027\u75be\u60a3\u30ec\u30b8\u30b9\u30c8\u30ea\u306e\u9032\u6357\u5831\u544a\u5831\u544a. \u4ee4\u548c2\u5e74\u5ea6AMED\u30fb\u539a\u52b4\u79d1\u7814\u8cbbHAM\u95a2\u9023\u7814\u7a76\u73ed\u5408\u540c\u73ed\u4f1a\u8b70. 2020. (12\u670813\u65e5,Zoom\u306b\u3088\u308bWeb\u958b\u50ac\u65b9\u5f0f)<\/li>\n
              4. \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. HTLV-1\u611f\u67d3\u3068\u81a0\u539f\u75c5\u30ea\u30a6\u30de\u30c1\u6027\u75be\u60a3\u306e\u708e\u75c7\u75c5\u614b. \u4ee4\u548c2\u5e74\u5ea6\u7b2c2\u56deHTLV-1\u6d5c\u53e3\u73ed\u4f1a\u8b70. 2021. (1\u670823\u65e5,Zoom Web\u4f1a\u8b70)<\/li>\n<\/ol>\n
                \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/a><\/div>\n

                C. \u305d\u306e\u4ed6<\/h3>\n
                  \n
                1. \u5bae\u5185\u4fca\u4e00. \u81a0\u539f\u75c5\u3063\u3066\u3001\u3069\u3093\u306a\u75c5\u6c17\uff1f \u306f\u307e\u3086\u3046. 2020; 67: 2-5.(5\u670822\u65e5)<\/li>\n
                2. \u6a4b\u5834\u5f25\u751f. \u5f53\u9662\u306e\u30b5\u30ea\u30eb\u30de\u30d6\u3092\u5c0e\u5165\u3057\u305f\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u75c7\u4f8b\u306e\u4e2d\u671f\u4f7f\u7528\u6210\u7e3e. \u7b2c34\u56de\u65e5\u672c\u81e8\u5e8a\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u8a18\u9332\u96c6. 2020. (6\u6708) \u65ed\u5316\u6210\u30d5\u30a1\u30fc\u30de\uff08\u682a\uff09\u30b5\u30ce\u30d5\u30a3(\u682a)<\/li>\n
                3. \u5ddd\u53e3\u525b, \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66, \u5c71\u4e2d\u7be4\u5fd7, \u5c71\u53e3\u54f2\u6717, \u539f\u8aa0\u4e00\u90ce. \u5bae\u5d0e\u770c\u306b\u304a\u3051\u308b\u65e5\u672c\u7d05\u6591\u71b1\u3068\u91cd\u75c7\u71b1\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\u5019\u7fa4\u306e\u81e8\u5e8a\u7684\u7279\u5fb4\u306e\u6bd4\u8f03. \u75c5\u539f\u5fae\u751f\u7269\u691c\u51fa\u60c5\u5831 41(8) 5. 2020. (8\u6708) \u611f\u67d3\u7814\u611f\u67d3\u75c7\u75ab\u5b66\u30bb\u30f3\u30bf\u30fc.<\/li>\n
                4. \u5ca1\u5c71\u662d\u5f66. \u7279\u96c6 \u30b3\u30ed\u30ca\u798d\u306b\u60f3\u3046\uff5e\u7be0\u61f8\u4f1a\u540c\u7a93\u751f\u304b\u3089\u306e\u58f0\uff5e \u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7. \u7be0\u61f8 \u7b2c31\u53f7. 2020.(12\u670823\u65e5)<\/li>\n
                5. \u9ad8\u57ce\u4e00\u90ce. \u7814\u7a76\u5ba4\u30fb\u8a3a\u7642\u79d1\u3060\u3088\u308a\u3000\u81a0\u539f\u75c5\u30fb\u611f\u67d3\u75c7\u5185\u79d1. \u7be0\u61f8 \u7b2c31\u53f7. 2020.(12\u670823\u65e5)<\/li>\n
                6. \u5ca1\u5c71\u662d\u5f66. \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u3068\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u6642\u4ee3\u306e\u611f\u67d3\u75c7\u4e88\u9632. \u6d41\u3000\u7279\u96c660\u5468\u5e74\u3092\u8fce\u3048\u3066. 2021; No357 \u901a\u5dfb5521: 5-11. (1\u670828\u65e5)<\/li>\n
                7. \u9ad8\u57ce\u4e00\u90ce. ICT\/AST\u30ec\u30dd\u30fc\u30c8\u300c\u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662 \u611f\u67d3\u5236\u5fa1\u90e8 ICT\/AST\u6d3b\u52d5\u7d39\u4ecb\u300d. iPacLetter. 2021;32 (3\u6708)\u674f\u6797\u88fd\u85ac(\u682a)<\/li>\n
                8. \u5ca1\u5c71\u662d\u5f66. \u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u306b\u3064\u3044\u3066\u3001\u6539\u3081\u3066\u77e5\u308a\u305f\u3044\u3053\u3068. \u5bae\u5d0e\u5927\u5b66\u30de\u30ac\u30b8\u30f3. 2021;36 (3\u670831\u65e5)\u5bae\u5d0e\u5927\u5b66\u5e83\u5831\u8a8c.<\/li>\n<\/ol>\n

                   <\/p>\n

                  \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/a><\/div>\n

                  D. \u7279\u8a31\u51fa\u9858<\/h3>\n

                  –<\/p>\n

                  \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/a><\/div>\n

                  \u5185\u8a33\u6570\uff082021\u5e744\u67085\u65e5\u6642\u70b9\uff09<\/span><\/h2>\n

                  A.\u8ad6\u6587\uff1a\u8457\u66f8(0), \u539f\u8457(8), \u75c7\u4f8b\u5831\u544a\uff08\u8ad6\u6587\uff09(4), \u7dcf\u8aac\uff083\uff09
                  \nB.\u767a\u8868\uff1a\u5b66\u4f1a\u767a\u8868\uff0817\uff09, \u7814\u7a76\u4f1a\u767a\u8868\uff085\uff09, \u8b1b\u6f14\u30fb\u30bb\u30df\u30ca\u30fc\uff0816\uff09, \u305d\u306e\u4ed6\uff084\uff09
                  \nC.\u305d\u306e\u4ed6\uff088\uff09, \t\u5b66\u4f1a\u4e3b\u50ac\u7b49\uff080\uff09
                  \nD.\u7279\u8a31\u51fa\u9858\uff080\uff09<\/p>\n","protected":false},"excerpt":{"rendered":"

                  A. \u8ad6\u6587 \u3010\u539f\u8457\u3011 Umekita K, Hashiba Y, Iwao K, Iwao C, Kimura M, Kariya Y, Kubo K, Miyauchi S, Kudou R, Rikitake Y, […]<\/p>\n","protected":false},"author":118,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false},"categories":[9,11],"tags":[],"_links":{"self":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts\/624"}],"collection":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/users\/118"}],"replies":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/comments?post=624"}],"version-history":[{"count":0,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts\/624\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/media?parent=624"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/categories?post=624"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/tags?post=624"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}